论文部分内容阅读
目的:对产前检查免疫检验项目的临床应用价值进行观察。方法:将在本院接受产前检查的100例孕产妇选为本次的观察对象,其检查时间均在2015年6月至2016年12月,经简单随机分组的方式将上述孕产妇分为两组,均为50例,分别为其实施常规产前检查(对照组)与产前检查免疫检验(观察组),观察其各项免疫检验的结果,并对两组孕产妇高危妊娠结果进行对比。结果:观察组中乙型肝炎阳性率为8.00%,丙型肝炎阳性率、梅毒抗体阳性率及TORCH感染阳性率均为2.00%,孕产妇经相关临床干预以后,观察组的高危妊娠概率明显较对照组低,P<0.05。结论:产前检查免疫检验项目可将科学可靠的依据提供给医学干预,有利于将孕产妇生育的质量提升,其临床价值较高,值得广泛应用。
Objective: To observe the value of clinical application of prenatal screening immunoassay. Methods: 100 pregnant women who received prenatal examination in our hospital were selected as the observation subjects. The examination time was from June 2015 to December 2016. The above mothers were divided into The two groups were 50 cases, respectively, for the implementation of routine prenatal care (control group) and prenatal examination of the immune test (observation group), observe the results of the various immunological tests, and two groups of high-risk pregnancy results of maternal Compared. Results: The positive rate of hepatitis B in the observation group was 8.00%, the positive rate of hepatitis C, the positive rate of syphilis antibody and the positive rate of TORCH infection were both 2.00%. After the relevant clinical intervention, the probability of high-risk pregnancy in observation group was significantly higher The control group was low, P <0.05. Conclusion: The prenatal immunization test can provide a scientific and reliable basis for medical intervention, which is beneficial to improve the quality of maternal birth and its clinical value is high, which is worthy of wide application.